You are here: Home
Categories

Adrenal and Kidney Conditions:

1. Beyond the Abstract - Watchful waiting and active surveillance approach in patients with low risk localized prostatic cancer: An experience of out-patients clinic with 12-year follow-up, by Sergey Kravchick, MD
BERKELEY, CA (UroToday.com) - Currently, the liberal use of PSA screening has doubled the detection rates of prostate cancer (PCa).
2. Beyond the Abstract - A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer, by Monique J. Roobol, MD, et al.
BERKELEY, CA (UroToday.com) - Despite recent results of the European Randomized Study of Screening for Prostate Cancer (ERSPC) that show relative mortality reduction up to 30% in favor of screening,
3. Beyond the Abstract - Phase II study of nitric oxide donor for men with increasing prostate-specific antigen level after surgery or radiotherapy for prostate cancer, by D. Robert Siemens, MD
BERKELEY, CA (UroToday.com) - You can teach an old dog new tricks
4. Beyond the Abstract - Trends in renal tumor surgery delivery within the United States, by Lori M. Dulabon, MD and William C. Huang, MD
BERKELEY, CA (UroToday.com) - Despite evidence of equivalent oncologic outcomes and a decreased risk of comorbid conditions such as chronic kidney disease, partial nephrectomy (PN) remains underutilized ...
5. Beyond the Abstract - Testosterone measurement in patients with prostate cancer, by Claude C. Schulman MD, PhD
BERKELEY, CA (UroToday.com) - Testosterone has been a key therapeutic target in prostate cancer for more than 60 years, and modern advances have enriched our understanding of the pathophysiological importance ...
6. Beyond the Abstract - Androgen deprivation therapy for prostate cancer: Recommendations to improve patient and partner quality of life, by Richard Wassersug, PhD, et al.
BERKELEY, CA (UroToday.com) - Much has happened with the use of androgen deprivation to treat prostate cancer (PCa) patients since Charles Huggins first castrated a patient in order to alleviate the symptoms ...
7. Beyond the Abstract - The language of emasculation: Implications for cancer patients, by Richard Wassersug, PhD, et al.
BERKELEY, CA (UroToday.com) - As part of their treatment for prostate cancer, approximately a half million men at any time in North America are on LHRH agonist drugs to lower their testosterone to castrate ...
8. Beyond the Abstract - A description of heterosexual couples' sexual adjustment to androgen deprivation therapy for prostate cancer, by Lauren M. Walker, PhD candidate
BERKELEY, CA (UroToday.com) - While erectile dysfunction may not be a new side effect for men who are starting on androgen deprivation therapy (ADT), the treatment does harbor many uniquely distressing ...
9. Beyond the Abstract - Infrared and Raman studies on renal stones: The use of second derivative infrared spectra, by José Rodolfo Guerra-López, MD and Jorge Alberto Güida, MD
BERKELEY, CA (UroToday.com) - Extending the analytical potentiality of infrared spectroscopy using the second derivative method applied to the analysis of renal stones
10. Beyond the Abstract - Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells, by Michele Caraglia, MD, PhD
BERKELEY, CA (UroToday.com) - Urotensin II (UT-II) is a potent vasoconstrictor peptide and its receptor (UTR) correlated with human cortico-adrenal carcinoma proliferation.
11. Beyond the Abstract - Does valproic acid induce neuroendocrine differentiation in prostate cancer? by Abhinav Sidana, MD
BERKELEY, CA (UroToday.com) - Histone acetylation and deacetylation by histone acetyl transferases and histone deacetylases (HDACs) is involved in the epigenetic regulation in human cells.1, 2
12. Beyond the Abstract - Adjuvant medical therapy for prostate cancer, by Thomas W. Flaig, MD
BERKELEY, CA (UroToday.com) - Even though prostate cancer is the most common cancer in men, the appropriate role of adjuvant medical therapy is largely undefined.
13. Beyond the Abstract - Role of estrogen in normal male function: Clinical implications for patients with prostate cancer on androgen deprivation therapy, by Richard J. Wassersug, et al.
BERKELEY, CA (UroToday.com) - The most common treatment for advanced prostate cancer (PCa) is androgen deprivation therapy achieved with luteinizing hormone-releasing hormone agonists (LHRHa).
14. Beyond the Abstract - The health and well-being of prostate cancer patients versus male-to-female transsexuals on androgen deprivation therapy: A qualitative study with comments on expectations and estrogen, by Richard Wassersug, PhD
BERKELEY, CA (UroToday.com) - This article was built upon information gleaned from interviews with male-to-female (MtF) transsexuals and prostate cancer (PCa) patients, all of whom were on androgen deprivation ...
15. Beyond the Abstract - Survival is associated with time to reach PSA nadir (DAN) and the ratio DAN/nadir value after androgen deprivation for prostate cancer, by Jacques Irani, MD
BERKELEY, CA (UroToday.com) - ADT is no longer the sole treatment of advanced prostate cancer (PCa); other treatments including chemotherapy, vaccination and new hormonal treatments that do not lead to ...
16. Perceived family health in persons with prostate cancer and their family members - Abstract
  To describe perceived family health in persons with prostate cancer and their family members. An additional purpose was to describe the associations between the background variables of persons ...
17. Beyond the Abstract - Disease-specific survival of men with prostate cancer detected during the screening interval: Results of the European Randomized Study of Screening for Prostate Cancer-Rotterdam after 11 years of follow-up, by Xiaoye Zhu, MD, et al.
BERKELEY, CA (UroToday.com) - In a screening program, interval cancers are cancers which are diagnosed between two screening visits.
18. Beyond the Abstract - Potential prostate cancer drug target: Bioactivation of androstanediol by conversion to dihydrotestosterone, by James L. Mohler, MD, Mark A. Titus, PhD and Elizabeth M. Wilson, PhD
BERKELEY, CA (UroToday.com) - Conversion of androstanediol to DHT by 17b-hydroxysteroid dehydrogenase-6 is a new target for prostate cancer drug therapy
19. Beyond the Abstract - Predictors of unfavourable repeat biopsy results in men participating in a prospective active surveillance program, by Meelan Bul, MD, et al.
BERKELEY, CA (UroToday.com) - Active surveillance (AS) for low-risk prostate cancer (PC) aims to prevent, or at least delay, invasive therapy and its potential side effects in carefully selected men, mainly ...
20. Beyond the Abstract - Pediatric adrenal trauma in the 21st century: Children's Hospital of Atlanta Experience, by Brad Figler, MD
BERKELEY, CA (UroToday.com) - The increasing use of computed tomography (CT) in the evaluation of trauma has uncovered an entirely new subset of patients - those with injuries that are minor and would ...